57 related articles for article (PubMed ID: 8778423)
1. Pregnancy in women under 35 with elevated early follicular phase follicle-stimulating hormone levels. A report of five cases.
Rose BI
J Reprod Med; 1996 Mar; 41(3):201-4. PubMed ID: 8778423
[TBL] [Abstract][Full Text] [Related]
2. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve.
Abdalla H; Thum MY
Hum Reprod; 2004 Apr; 19(4):893-8. PubMed ID: 15016786
[TBL] [Abstract][Full Text] [Related]
3. Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone.
Cabrera RA; Stadtmauer L; Mayer JF; Gibbons WE; Oehninger S
Fertil Steril; 2005 Jan; 83(1):42-8. PubMed ID: 15652885
[TBL] [Abstract][Full Text] [Related]
4. The endocrine and follicular growth dynamics throughout the menstrual cycle in women with consistently or variably elevated early follicular phase FSH compared with controls.
de Koning CH; McDonnell J; Themmen AP; de Jong FH; Homburg R; Lambalk CB
Hum Reprod; 2008 Jun; 23(6):1416-23. PubMed ID: 18375407
[TBL] [Abstract][Full Text] [Related]
5. [Recovery of ovarian function after radiation-induced menopause. Does follicle-stimulating hormone (FSH) have a definitive prognostic value?].
Letur-Könirsch H; Guis F
C R Acad Sci III; 1996 Oct; 319(10):907-12. PubMed ID: 8977771
[TBL] [Abstract][Full Text] [Related]
6. Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify patients from attempting in vitro fertilization.
Luna M; Grunfeld L; Mukherjee T; Sandler B; Copperman AB
Fertil Steril; 2007 Apr; 87(4):782-7. PubMed ID: 17207802
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of ovarian follicular reserve].
Loumaye E
Contracept Fertil Sex; 1993 May; 21(5):399-402. PubMed ID: 7920928
[TBL] [Abstract][Full Text] [Related]
8. Repeated testing of basal FSH levels has no predictive value for IVF outcome in women with elevated basal FSH.
Abdalla H; Thum MY
Hum Reprod; 2006 Jan; 21(1):171-4. PubMed ID: 16155077
[TBL] [Abstract][Full Text] [Related]
9. Women with consistently or variably elevated early follicular phase FSH.
Cahill D; El Hakim E
Hum Reprod; 2009 Mar; 24(3):757-8; author reply 758. PubMed ID: 19073615
[No Abstract] [Full Text] [Related]
10. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function.
Barad DH; Weghofer A; Gleicher N
Obstet Gynecol; 2007 Jun; 109(6):1404-10. PubMed ID: 17540814
[TBL] [Abstract][Full Text] [Related]
11. Estimation of the follicle-stimulating hormone (FSH) threshold for initiating the final stages of follicular development in women with elevated FSH levels in the early follicular phase.
de Koning CH; Schoemaker J; Lambalk CB
Fertil Steril; 2004 Sep; 82(3):650-3. PubMed ID: 15374709
[TBL] [Abstract][Full Text] [Related]
12. [FSH and IVF management: the best and worst case scenarios].
Aubriot FX; Chapron C
Gynecol Obstet Fertil; 2008 Jun; 36(6):636-40. PubMed ID: 18538623
[TBL] [Abstract][Full Text] [Related]
13. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
14. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
15. Taking a basal follicle-stimulating hormone history is essential before initiating in vitro fertilization.
Roberts JE; Spandorfer S; Fasouliotis SJ; Kashyap S; Rosenwaks Z
Fertil Steril; 2005 Jan; 83(1):37-41. PubMed ID: 15652884
[TBL] [Abstract][Full Text] [Related]
16. Elevated day 3 follicle-stimulating hormone/luteinizing hormone ratio >or= 2 is associated with higher rates of cancellation in in vitro fertilization-embryo transfer cycles.
Liu KE; Greenblatt EM
Fertil Steril; 2008 Aug; 90(2):297-301. PubMed ID: 18023434
[TBL] [Abstract][Full Text] [Related]
17. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
[TBL] [Abstract][Full Text] [Related]
18. Reproductive ageing and ovarian function: is the early follicular phase FSH rise necessary to maintain adequate secretory function in older ovulatory women?
Hansen KR; Thyer AC; Sluss PM; Bremner WJ; Soules MR; Klein NA
Hum Reprod; 2005 Jan; 20(1):89-95. PubMed ID: 15550499
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of obesity on gonadotropin, estradiol, and inhibin B levels in fertile women.
De Pergola G; Maldera S; Tartagni M; Pannacciulli N; Loverro G; Giorgino R
Obesity (Silver Spring); 2006 Nov; 14(11):1954-60. PubMed ID: 17135611
[TBL] [Abstract][Full Text] [Related]
20. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
